Greg Conn

City:

Madrid

Country:

Spain

Published Applications:

Last publication date:

2023-09-14

Top Assignees for applications by Greg Conn

The entities that hold a legal rights for patent applications filed by inventor Conn Greg:

PDS BIOTECHNOLOGY CORPORATION 2 North Brunswick, NJ United States
PDS Biotechnology Corporalion 1 North Brunswick, NJ United States

Recent patent applications by Conn Greg

Greg Conn from Madrid, ES has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-14

US20230285551A1

Human necessities

LIPIDS AS SYNTHETIC VECTORS TO ENHANCE ANTIGEN PROCESSING AND PRESENTATION EX-VIVO IN DENDRITIC CELL THERAPY

#2 | 2023-02-16

US20230052399A1

Human necessities

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

#3 | 2022-10-20

US20220332768A1

Chemistry; metallurgy

NOVEL HPV16 NON HLA-RESTRICTED T-CELL VACCINES, COMPOSITIONS AND METHODS OF USE THEREOF

#4 | 2022-05-26

US20220160867A1

Human necessities

METHODS AND COMPOSITIONS COMPRISING CATIONIC LIPIDS FOR IMMUNOTHERAPY BY DIRECT TUMOR INJECTION

#5 | 2019-11-28

US20190358319A1

Human necessities

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

#6 | 2019-10-24

US20190321321A1

Human necessities

METHODS AND COMPOSITIONS COMPRISING CATIONIC LIPIDS FOR STIMULATING TYPE 1 INTERFERON GENES

#7 | 2018-12-13

US20180353599A1

Human necessities

Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy

#8 | 2018-08-09

US20180221475A1

Human necessities

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

#9 | 2018-04-05

US20180094032A1

Chemistry; metallurgy

HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

InventorID:

2156859 ⎘